Report cover image

Ovarian Cancer Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Aug 16, 2024
Length 123 Pages
SKU # PROD19315674

Description

Ovarian Cancer Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global ovarian cancer market is expected to grow at a CAGR of around 11.2% during 2025-2034. This report on global ovarian cancer market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global ovarian cancer market by segmenting the market based on type, treatment type, drugs, end user, and region. Also, detailed profiles of companies operating in the ovarian cancer market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

● Rise in the Elderly Women's Population
● Rising Healthcare Awareness

Market Challenges

● Lack of Skilled Professionals
● Unavailability of Adequate Technology

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Type

● Epithelial Ovarian Cancer
● Germ Cell Ovarian Cancer
● Stromal Cell Ovarian Cancer
● Primary Peritoneal Cancer

Market by Treatment Type

● Immunotherapy
● Chemotherapy
● Targeted Therapy
● Surgery
● Others

Market by Drugs

● Mitotic Inhibitors
● Antirheumatics
● Antipsoriatics
● VEGF/VEGFR Inhibitors
● PARP Inhibitors
● Antineoplastics
● Others

Market by End User

● Hospitals
● Homecare
● Speciality Centre
● Others


Market by Region

● Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
● North America
United States
Canada
● Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
● Latin America
Mexico
Brazil
Argentina
Rest of Latin America
● Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

123 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Ovarian Cancer Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Ovarian Cancer Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Ovarian Cancer Market by Type
5.1. Introduction
5.2. Epithelial Ovarian Cancer
5.3. Germ Cell Ovarian Cancer
5.4. Stromal Cell Ovarian Cancer
5.5. Primary Peritoneal Cancer
6. Global Ovarian Cancer Market by Treatment Type
6.1. Introduction
6.2. Immunotherapy
6.3. Chemotherapy
6.4. Targeted Therapy
6.5. Surgery
6.6. Others
7. Global Ovarian Cancer Market by Drugs
7.1. Introduction
7.2. Mitotic Inhibitors
7.3. Antirheumatics
7.4. Antipsoriatics
7.5. VEGF/VEGFR Inhibitors
7.6. PARP Inhibitors
7.7. Antineoplastics
7.8. Others
8. Global Ovarian Cancer Market by End User
8.1. Introduction
8.2. Hospitals
8.3. Homecare
8.4. Speciality Centre
8.5. Others
9. Global Ovarian Cancer Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. AbbVie
13.2.2. Aetera Zenteris Inc.
13.2.3. AstraZeneca
13.2.4. Boehringer Ingelheim GmbH
13.2.5. Bristol-Myers Squibb
13.2.6. Clovis Oncology
13.2.7. Eli Lilly and Company
13.2.8. Genentech Inc.
13.2.9. GlaxoSmithKline plc
13.2.10. ImmunoGen
13.2.11. Janssen Pharmaceuticals, Inc.
13.2.12. Johnson & Johnson
13.2.13. Novogen, Inc.
13.2.14. Oasmia Pharmaceuticals
13.2.15. Pfizer
13.2.16. Roche Ltd.
13.2.17. Tesaro Inc.
List of Figures
Figure 1: Global Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 2: Global Ovarian Cancer Market by Type, 2024
Figure 3: Global Ovarian Cancer Market by Treatment Type, 2024
Figure 4: Global Ovarian Cancer Market by Drugs, 2024
Figure 5: Global Ovarian Cancer Market by End User, 2024
Figure 6: Global Ovarian Cancer Market by Region, 2024
Figure 7: Global Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 8: Global Ovarian Cancer Market by Type (in %), 2024 & 2034
Figure 9: Global Epithelial Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 10: Global Epithelial Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 11: Global Germ Cell Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 12: Global Germ Cell Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 13: Global Stromal Cell Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 14: Global Stromal Cell Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 15: Global Primary Peritoneal Cancer Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 16: Global Primary Peritoneal Cancer Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 17: Global Ovarian Cancer Market by Treatment Type (in %), 2024 & 2034
Figure 18: Global Immunotherapy Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 19: Global Immunotherapy Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 20: Global Chemotherapy Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 21: Global Chemotherapy Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 22: Global Targeted Therapy Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 23: Global Targeted Therapy Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 24: Global Surgery Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 25: Global Surgery Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 26: Global Other Treatment Types Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 27: Global Other Treatment Types Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 28: Global Ovarian Cancer Market by Drugs (in %), 2024 & 2034
Figure 29: Global Mitotic Inhibitors Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 30: Global Mitotic Inhibitors Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 31: Global Antirheumatics Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 32: Global Antirheumatics Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 33: Global Antipsoriatics Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 34: Global Antipsoriatics Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 35: Global VEGF/VEGFR Inhibitors Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 36: Global VEGF/VEGFR Inhibitors Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 37: Global PARP Inhibitors Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 38: Global PARP Inhibitors Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 39: Global Antineoplastics Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 40: Global Antineoplastics Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 41: Global Other Drugs Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 42: Global Other Drugs Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 43: Global Ovarian Cancer Market by End User (in %), 2024 & 2034
Figure 44: Global Hospitals Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 45: Global Hospitals Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 46: Global Homecare Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 47: Global Homecare Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 48: Global Speciality Centre Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 49: Global Speciality Centre Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 50: Global Other End Users Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 51: Global Other End Users Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 52: Global Ovarian Cancer Market by Region (in %), 2024 & 2034
Figure 53: Europe Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 54: Europe Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 55: Europe Ovarian Cancer Market by Country (in %), 2024 & 2034
Figure 56: Germany Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 57: United Kingdom Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 58: France Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 59: Italy Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 60: Spain Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 61: Russia Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 62: Netherlands Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 63: North America Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 64: North America Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 65: North America Ovarian Cancer Market by Country (in %), 2024 & 2034
Figure 66: United States Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 67: Canada Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 68: Asia Pacific Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 69: Asia Pacific Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 70: Asia Pacific Ovarian Cancer Market by Country (in %), 2024 & 2034
Figure 71: China Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 72: Japan Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 73: India Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 74: South Korea Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 75: Australia Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 76: Indonesia Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 77: Latin America Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 78: Latin America Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 79: Latin America Ovarian Cancer Market by Country (in %), 2024 & 2034
Figure 80: Mexico Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 81: Brazil Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 82: Argentina Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 83: Middle East & Africa Ovarian Cancer Market (in US$ Million), 2020-2024
Figure 84: Middle East & Africa Ovarian Cancer Market (in US$ Million), 2025-2034
Figure 85: Middle East & Africa Ovarian Cancer Market by Country (in %), 2024 & 2034
Figure 86: Saudi Arabia Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 87: Turkey Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 88: Iran Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 89: UAE Ovarian Cancer Market (in US$ Million), 2020-2034
Figure 90: Market Value Chain
List of Tables
Table 1: Global Ovarian Cancer Market Portraiture
Table 2: Global Ovarian Cancer Market by Type (in US$ Million), 2024 & 2034
Table 3: Global Ovarian Cancer Market by Treatment Type (in US$ Million), 2024 & 2034
Table 4: Global Ovarian Cancer Market by Drugs (in US$ Million), 2024 & 2034
Table 5: Global Ovarian Cancer Market by End User (in US$ Million), 2024 & 2034
Table 6: Global Ovarian Cancer Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Ovarian Cancer Market by Country (in US$ Million), 2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us